View drug registration information details.


ItemsRegistration information
ID2447
No2447
Brand NameCABONNI
IngredientsCABOZANTINIB 20 MG
Dosage FormCAPSULE
Primary PackagingBottle
Storage
Shelf Life2 YEARS
Pack Size90 'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTO TREAT MEDULLARY THYROID CANCER, A RARE TYPE OF TYPHOID CANCER THAT CANNOT BE REMOVED BY SURGERY OR THAT HAS SPRERAD TO OTHER PARTS OF THE BODY
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionHARD CAPSULES. THE CONTENTS OF THE CAPSULES ARE OFF-WHITE POWDER OR GRANULES
Note
License OwnerTONGMENG( LAO) PHARMACEUTICAL CO.LTD
ManufacturerTONGMENG( LAO) PHARMACEUTICAL AND FOOD CO.LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No02 L 0842/21
FDD Registration Date21-AUG-2024
Expiry Date20-AUG-2027

Back to drug list